Students Against Nicotine (SAN) Scientific Advisory Board
Disclaimer: The members of this Board each have independent views on the legislative policies for which SAN advocates. Their affiliation here is not an endorsement of SAN's policy priorities.
|
David J. Feller-Kopman, M.D.
Chief, Pulmonary, and Critical Care Medicine Professor of Medicine Dartmouth-Hitchcock Medical Center Hanover, New Hampshire Dr. Feller-Kopman earned his M.D. from the George Washington University School of Medicine. He completed his residency at Beth Israel Deaconess Medical Center and performed a combined fellowship in pulmonary and critical care medicine at Beth Israel Deaconess Medical Center. Dr. Feller-Kopman's areas of clinical expertise include bronchoscopy, critical care medicine and interventional pulmonology and improving the multidisciplinary treatment of patients with complex airway disease. He is a past president of the American Association for Bronchology and Interventional Pulmonology. He has been recognized with the Geoffrey McLennan Memorial Award for Advances in Interventional Pulmonology by the American Association for Bronchology and Interventional Pulmonology, and received the Pasquale Ciaglia Award from the American College of Chest Physicians. He was recently inducted into the Miller-Coulson Academy of Clinical Excellence at the Johns Hopkins University School of Medicine. Erika Berman Rosenzweig, M.D.
Director, Pulmonary Hypertension Center Professor of Pediatric Cardiology Columbia Presbyterian Medical Center New York Dr. Rosenzweig is Director of the Pulmonary Hypertension Center at Columbia University Medical Center/NewYork-Presbyterian Hospital and the CTEPH Program at CUMC, and is considered an international expert in the field of pulmonary hypertension. She has tremendous clinical and research experience in the fields of adult and pediatric pulmonary hypertension. Dr. Rosenzweig is widely published and has devoted remarkable efforts toward clinical research on the study of novel treatments and genetic causes of pulmonary hypertension as well as novel approaches to mechanical support for patients with end-stage pulmonary hypertension. She has been an active member of the Pulmonary Hypertension Association (PHA) and is currently on the Board of Trustees of the PHA, Immediate past Chair of the Scientific Leadership Council of the PHA, past Chair of the Review Committee for PHCC PH Center Accreditation Program, and past Editor-in Chief of the medical journal Advances in Pulmonary Hypertension. Joseph N. Cappella, Ph.D.
Faculty, Tobacco Center of Regulatory Science (TCORS) Professor of Communication University of Pennsylvania Philadelphia Dr. Cappella has been a visiting professor at Northwestern University, the University of Arizona, and a visiting scholar at Stanford University and the University of California, Santa Barbara. His research has resulted in more than 165 articles and book chapters and four co-authored books in areas of health and political communication, social interaction, nonverbal behavior, media effects, and statistical methods. The articles have appeared in journals of psychology, communication, health, and politics. He has served on the editorial boards of 20 different journals and directed 46 doctoral dissertations. He is a Fellow of the International Communication Association and its past president, a distinguished scholar of the National Communication Association, and recipient of the B. Aubrey Fisher Mentorship Award. His book with Kathleen Hall Jamieson entitled Spiral of Cynicism has been awarded the Doris Graber book award from the American Political Science Association and the Fellows Book Award from the International Communication Association. His recent research includes "Temporal Effects of Message Congruency on Attention to and Recall of Pictorial Health Warning Labels on Cigarette Packages." and "The Measurement of the Public’s Knowledge as the Basis for Assessing Misinformation: Application to Tobacco Products." Hanno C. Erythropel, Ph.D.
Associate Research Scientist, Tobacco Center of Regulatory Science (TCORS) Yale University New Haven, CT Dr. Erythropel received his Ph.D. and MSc degrees from McGill University. From his prior experience, Dr. Erythropel is passionate about the interfaces of chemistry with toxicology and material science, respectively. Currently, he is using his expertise to better understand the health implications of “vaped” e-cigarette liquid by determining what kind of chemical transformations occur. He was recently the lead author on a study which found that chemical reactions in flavored liquids of the popular Juul e-cigarette create unexpected chemicals, including acetals, that can irritate users’ airways (https://news.yale.edu/2019/07/30/juul-users-inhaling-chemicals-not-listed) |
|
